IMMU-114

Known as: Anti-HLA-DR Monoclonal Antibody IMMU-114 
A humanized IgG4 monoclonal antibody that targets the human leukocyte antigen HLA-DR, with potential antineoplastic activity. Upon administration… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2018
02420062018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
HLA-DR is a member of the MHC class II antigen family expressed on hematologic and solid tumors. Antibodies directed against HLA… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2012
2012
In contrast to the conventional immunosuppressive agents and nonselective T-cell-depleting antibodies, selective depletion of… (More)
  • figure 1
  • figure 3
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
BACKGROUND The effect of a humanized anti-human leukocyte antigen-DR monoclonal antibody, IMMU-114, on the allogeneic immune… (More)
Is this relevant?
2012
2012
UNLABELLED The effect of an anti-human leukocyte antigen-DR (MHC class II) humanized monoclonal antibody, IMMU-114, against the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
A pilot study of anti-human leukocyte antigen (HLA)-DR monoclonal antibody (mAb) in dogs with lymphoma was undertaken to verify… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I
Is this relevant?
2010
2010
A humanized IgG4 anti-HLA-DR monoclonal antibody (IMMU-114), engineered to avoid side effects associated with complement… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2010
2010
The short circulating half-life and side effects of IFNα affect its dosing schedule and efficacy. Fusion of IFNα to a tumor… (More)
Is this relevant?
2010
2010
Download short circulating half-life and side effects of IFNα affect its dosing schedule and efficacy. Fusion of IFNα mor… (More)
Is this relevant?
2010
2010
114, specifically looking at JNK-MAPK signaling activation. The MAPK pathway is constitutively active in several hematologic… (More)
Is this relevant?